敲响警钟

[1]  王迁, 李梦涛, 曾小峰. 系统性红斑狼疮相关肺动脉高压的诊治共识. 中国临床医生杂志. 2015. (7): 10-12.

[2] Pan TL, Thumboo J, Boey ML. Primary and secondary pulmonary hypertension in systemic lupus erythematosus. Lupus. 2000. 9(5): 338-42.

[3] Fei Y, Shi X, Gan F, et al. Death causes and pathogens analysis of systemic lupus erythematosus during the past 26 years. Clin Rheumatol. 2014. 33(1): 57-63.

[4]  张巍, 张春燕, 鲍春德. 系统性红斑狼疮合并肺动脉高压十年住院病例分析. 中华风湿病学杂志. 2013. 17(1): 16-19.

[5] Winslow TM, Ossipov MA, Fazio GP, Simonson JS, Redberg RF, Schiller NB. Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus. Am Heart J. 1995. 129(3): 510-5.

[6] 国家风湿病数据中心, 中国系统性红斑狼疮研究协作组. 中国成人系统性红斑狼疮相关肺动脉高压诊治共识. 中华内科杂志. 2015. 54(1): 81-86.

[7] 徐季超, 魏强华. 系统性红斑狼疮患者发生肺动脉高压危险因素的 Meta 分析. 中国全科医学. 2016. 19(17): 2078-2082,2083.

[8] Prabu A, Gordon C. Pulmonary arterial hypertension in SLE: what do we know. Lupus. 2013. 22(12): 1274-85.

[9] Sanges S, Launay D, Rhee RL, et al. A prospective study of the 6 min walk test as a surrogate marker for haemodynamics in two independent cohorts of treatment-naïve systemic sclerosis-associated pulmonary arterial hypertension. Ann Rheum Dis. 2016. 75(8): 1457-65.

[10] 张丽卿, 李梦涛, 曾小峰, 姚冬云. 系统性红斑狼疮肺动脉高压63例临床分析. 中华风湿病学杂志. 2008. 12(9): 626-628.

[11] 董馨, 郑毅, 陈曦. 系统性红斑狼疮合并肺动脉高压23例临床分析. 中华风湿病学杂志. 2007. 11(10): 609-612.

[12] Jais X, Launay D, Yaici A, et al. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases. Arthritis Rheum. 2008. 58(2): 521-31.

[13] Sitbon O, Jaïs X, Savale L, et al. Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study. Eur Respir J. 2014. 43(6): 1691-7.